Enter assignee name

EPO Patents = 3

Forward Citations = 21

Loading Chart...

4 inventors (with patents filed for the assignee):

Fahar Merchant (10 out of 10 patents)

Raj K Puri (2 out of 13 patents)

Bharatkumar H Joshi (2 out of 2 patents)

4. Shafique Fidai (2 out of 2 patents)

10 patents: Sort by Forward Citations

1. 12404497 - Uses and methods for oncolytic virus targeting of IL-4/IL-13 and fusions thereof (2025-09-02),

2. 12338269 - IL-2 superagonists in combination with anti-PD-1 antibodies (2025-06-24),

3. 12274735 - IL-4-fusion formulations for treatment of central nervous system (CNS) tumors (2025-04-14),

4. 11680090 - Interleukin-2 fusion proteins and uses thereof (2023-06-20),

5. 11542312 - IL-2 superagonists in combination with anti-PD-1 antibodies (2023-01-03),

6. 11352402 - Interleukin-4 receptor-binding fusion proteins and uses thereof (2022-06-07),

7. 11084856 - Interleukin-4 receptor-binding fusion proteins and uses thereof (2021-08-10),

8. 10781242 - Interleukin-2 fusion proteins and uses thereof (2020-09-22),

9. 10106592 - Interleukin-4 receptor-binding fusion proteins and uses thereof (2018-10-23),

10. 10093708 - Interleukin-4 receptor-binding fusion proteins and uses thereof (2018-10-09),

Medicenna is a clinical stage immuno-oncology company developing novel therapies against cancer. Their lead drug candidate, MDNA55, targets a unique receptor found on the cells of numerous cancers including brain, sarcoma, and others. Medicenna is dedicated to improving patient outcomes through innovative cancer treatments.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

10 Patents

#89 in Vancouver

#1,468 in Canada

#54,308 in the World

Vancouver, Canada

Medicenna Therapeutics, Inc.

Forward Citations = 21

4 inventors:

Fahar Merchant (10 out of 10 patents)

Raj K Puri (2 out of 13 patents)

Bharatkumar H Joshi (2 out of 2 patents)

4. Shafique Fidai (2 out of 2 patents)

Please report any incorrect information to support@idiyas.com